Pharmaceutical Related Topics 
Veriheal
OCTOBER 3, 2022
With the growing acceptance and legalization of cannabis, the pharmaceutical industry is taking serious hits, according to a 2022 novel study into the impact of cannabis legalization on pharmaceutical firms. What Is the Pharmaceutical Industry? pharmaceuticals).
Cannabis Life Network
MARCH 31, 2021
Because of its broad range of effects, cannabis can cause a variety of interactions with pharmaceutical drugs. The post How does cannabis interact with pharmaceutical drugs? A drug interaction happens when two or more compounds come in contact with each other and create an effect.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
APRIL 11, 2022
The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis.
The Fresh Toast
NOVEMBER 21, 2020
More Women Switch Out Pharmaceuticals For Medical Marijuana. The post More Women Switch Out Pharmaceuticals For Medical Marijuana appeared first on The Fresh Toast. Medical Marijuana News Endometriosis gynecology menopause pharmaceuticals prescription drugs women
Cannabis Law Report
JANUARY 17, 2023
Celadon Pharmaceuticals PLC shares rose on Monday after the company said that its Midlands facility has been registered for the good manufacturing practice standard by the U.K.’s The UK-based pharmaceutical company focused on […].
Cannabis Law Report
JANUARY 23, 2023
VF1883 Pharmaceuticals, a medical cannabis producer based in Benavente, has been declared insolvent by the Santarém Court.
The Fresh Toast
MARCH 20, 2019
Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. The post Consumers Are Replacing Pharmaceuticals With Medical Marijuana appeared first on The Fresh Toast. Cannabis Medical Marijuana News opioids pharmaceuticals
Cannabis Law Report
MARCH 9, 2021
While other cannabis industry SPAC’s have seemed to make big splashy entrances to the market, Ibere Pharmaceuticals quietly closed on… Read More. The post Ibere Pharmaceuticals Is The Quiet SPAC first appeared on Cannabis Law Report.
Cannabis Law Report
MARCH 15, 2021
Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report. NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020.…
Cannabis Law Report
MARCH 21, 2022
The Global Cannabis Pharmaceuticals Market size was estimated at USD 872.57 Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, sleep disorders, and others. Botanix Pharmaceuticals. Corbus Pharmaceuticals Holdings, Inc.
Medical Marijuana Program Connection
JANUARY 18, 2023
–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. Read More. Business
Cannabis Law Report
MAY 12, 2021
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More. Business Wire
Cannabis Law Report
OCTOBER 25, 2022
The transformative deal is expected to connect Flora Growth’s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution.
Cannabis Law Report
NOVEMBER 9, 2022
The Cannabis Pharmaceuticals Market is estimated to be USD 1.2
Cannabis Law Report
MARCH 18, 2021
Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.
Cannabis Law Report
SEPTEMBER 2, 2021
In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products. The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space.
Cannabis Law Report
JANUARY 18, 2023
–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS
Cannabis Law Report
JUNE 17, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. The post Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition appeared first on Green Market Report.
Cannabis Law Report
MARCH 31, 2022
–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. –Company Advances All Pre-Clinical Programs– BERWYN, Pa.–(BUSINESS
Cannabis Law Report
SEPTEMBER 26, 2022
AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.
Cannabis Law Report
SEPTEMBER 20, 2022
AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.
Cannabis Law Report
NOVEMBER 30, 2022
–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. RADNOR, Pa.–(BUSINESS
Medical Marijuana Program Connection
JANUARY 24, 2023
KALKASKA, Mich.–(BUSINESS –(BUSINESS WIRE)–Colorado-based cannabis brand Escape Artists, a top-selling maker of infused topicals for pain relief and recovery, today announced. Read More Business
Cannabis Law Report
MAY 12, 2020
GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.
Cannabis Law Report
MARCH 16, 2022
The United States Cannabis Pharmaceuticals Market size was estimated at USD 168.41 Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cannabis Pharmaceuticals Market, including.
Cannabis Law Report
JULY 23, 2021
Users are looking for safer alternatives to opioids, antidepressants, and arthritis relief. Green Entrepreneur
Cannabis Law Report
JANUARY 18, 2023
UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East.
Cannabis Law Report
DECEMBER 14, 2022
–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. –VRPX Intranasal Cannabidiol Product Candidate for Management of Epilepsy in Children and Adults– BERWYN, Pa.–(BUSINESS
Cannabis Law Report
DECEMBER 23, 2021
DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. GW Pharmaceuticals.
Cannabis Law Report
APRIL 6, 2022
MARSA, Malta–(BUSINESS WIRE)–A2W Pharma Ltd, a pharmaceutical company based in Malta, celebrates the opening of its new facility during a launch event on its premises today.
Cannabis Law Report
AUGUST 15, 2022
–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. –Company Advances Product Candidate Pipeline—.
Cannabis Law Report
MAY 24, 2022
AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. in pharmaceutical sciences from the University of Kentucky and postdoctoral training in Biochemistry at the University of California, Berkeley. About Anebulo Pharmaceuticals, Inc.
Cannabis Law Report
MARCH 20, 2021
Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.
Cannabis Law Report
APRIL 13, 2021
Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.
Cannabis Law Report
FEBRUARY 3, 2021
The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV
Cannabis Law Report
JUNE 7, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. About MyMD Pharmaceuticals, Inc.
Cannabis Law Report
APRIL 16, 2021
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol “MYMD“ Upon… Read More. Business Wire
Expert insights. Personalized for you.
84 
Let's personalize your content